{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T16:47:01Z","timestamp":1775753221587,"version":"3.50.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cervical cancer screening is a life-saving endeavour. The introduction of an organized population-based national screening programmes has potential to both reduce incidence of cervical cancer in an asymptomatic population and detect early-stage cancers for accelerated treatment. A methodology for estimating cancers prevented by such programmes has immediate utility. This work derives a model for estimating cancer prevented by screening, applied to data from Ireland\u2019s organized national cervical screening programme since its introduction in August 2008 to August 2022. A novel Markov-chain model for human papilloma virus (HPV) induced cervical cancer was derived with realistic transition probabilities validated against literature estimates. Data from the Irish National Screening Programme (CervicalCheck) and from the National Cancer Registry of Ireland (NCRI) was applied to estimate the number of cancers prevented by screening, changes in Irish cancer detection since the implementation of screening, and treatment costs saved by screening. Since its inception in 2008, the modelling in this work suggests that CervicalCheck has prevented an estimated 5557 cancers (95% confidence interval: 5114\u20136000 cancers) and saved \u20ac102 million in future treatment costs (95% confidence interval: \u20ac94\u2013110 million) not including inflation costs. Additionally, 48.8% (95% confidence interval: 41.4%\u201356.2%) of all cervical cancers in Ireland have been detected through screening between 2008 and 2022. National screening in Ireland has been highly effective at reducing future cervical cancers, and detecting asymptomatic cancers. The model outlined here has direct future applicability for the assessment of national and regional cervical cancer screening programmes.<\/jats:p>","DOI":"10.1093\/eurpub\/ckaf225","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:06:49Z","timestamp":1764162409000},"source":"Crossref","is-referenced-by-count":0,"title":["A method of estimating cervical cancers prevented by the introduction of national screening in Ireland"],"prefix":"10.1093","volume":"36","author":[{"given":"David Robert","family":"Grimes","sequence":"first","affiliation":[{"name":"TCD Biostatistics Unit, Discipline of Public Health and Primary Care, School of Medicine, Trinity College Dublin , Dublin, D24 DH74,","place":["Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline","family":"Brennan","sequence":"additional","affiliation":[{"name":"National Cancer Registry Ireland , Cork Airport Business Park, Kinsale Road , Cork, T12 CDF7,","place":["Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathal","family":"Walsh","sequence":"additional","affiliation":[{"name":"TCD Biostatistics Unit, Discipline of Public Health and Primary Care, School of Medicine, Trinity College Dublin , Dublin, D24 DH74,","place":["Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"2026040911294350600_ckaf225-B1","volume-title":"WHO Guideline for Screening and Treatment of Cervical Pre-Cancer Lesions for Cervical Cancer Prevention","author":"WHO","year":"2021","edition":"2nd edn"},{"key":"2026040911294350600_ckaf225-B2","volume-title":"Cancer Trends 35\u2014Cervical Cancer","author":"National Cancer Registry Ireland","year":"2017"},{"key":"2026040911294350600_ckaf225-B3","author":"CervicalCheck","year":"2022"},{"key":"2026040911294350600_ckaf225-B4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/LGT.0000000000000604","article-title":"The natural history of cervical intraepithelial neoplasia grades 1, 2, and 3: a systematic review and meta-analysis","volume":"25","author":"Loopik","year":"2021","journal-title":"J Low Genit Tract Dis"},{"key":"2026040911294350600_ckaf225-B5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12916-022-02291-7","article-title":"An international consensus on the essential and desirable criteria for an \u2018organized\u2019 cancer screening programme","volume":"20","author":"Zhang","year":"2022","journal-title":"BMC Med"},{"key":"2026040911294350600_ckaf225-B6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia\u2013grade 2","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"key":"2026040911294350600_ckaf225-B7","volume-title":"Williams\u2019 Gynecology","author":"Bradshaw","year":"2008"},{"key":"2026040911294350600_ckaf225-B8","doi-asserted-by":"crossref","first-page":"k499","DOI":"10.1136\/bmj.k499","article-title":"Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis","volume":"360","author":"Tainio","year":"2018","journal-title":"BMJ"},{"key":"2026040911294350600_ckaf225-B9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2020.01.023","article-title":"The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: a population-based cohort study with 80,442 women","volume":"157","author":"Loopik","year":"2020","journal-title":"Gynecol Oncol"},{"key":"2026040911294350600_ckaf225-B10","first-page":"451","article-title":"The invasive potential of carcinoma in situ of the cervix","volume":"64","author":"McIndoe","year":"1984","journal-title":"Obstet Gynecol"},{"key":"2026040911294350600_ckaf225-B11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/bjc.1989.236","article-title":"Natural history of cervical neoplasia: consistent results obtained by an identification technique","volume":"60","author":"Gustafsson","year":"1989","journal-title":"Br J Cancer"},{"key":"2026040911294350600_ckaf225-B12","volume-title":"Diagnostic Pathology: Molecular Oncology","author":"Vasef","year":"2019"},{"key":"2026040911294350600_ckaf225-B13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(04)16674-9","article-title":"The cervical cancer epidemic that screening has prevented in the UK","volume":"364","author":"Peto","year":"2004","journal-title":"Lancet"},{"key":"2026040911294350600_ckaf225-B14","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1600-0463.2007.00769.x","article-title":"Cervical intraepithelial neoplasia grade 3 lesions can regress","volume":"115","author":"Munk","year":"2007","journal-title":"APMIS"},{"key":"2026040911294350600_ckaf225-B15","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/sj.bjc.6601196","article-title":"HPV infection and number of lifetime sexual partners are strong predictors for \u2018natural\u2019 regression of CIN 2 and 3","volume":"89","author":"Chan","year":"2003","journal-title":"Br J Cancer"},{"key":"2026040911294350600_ckaf225-B16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00404-022-06680-4","article-title":"Regression rate of high-grade cervical intraepithelial lesions in women younger than 25 years","volume":"307","author":"Ehret","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"2026040911294350600_ckaf225-B17","volume-title":"Grinstead and Snell\u2019s Introduction to Probability","author":"American Mathematical Society","year":"1997"},{"key":"2026040911294350600_ckaf225-B18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"2026040911294350600_ckaf225-B19","author":"CervicalCheck","year":"2024"},{"key":"2026040911294350600_ckaf225-B20","author":"National Cancer Registry Ireland","year":"2020"},{"key":"2026040911294350600_ckaf225-B21","volume-title":"Estimates of the Health Service Costs of Cancers Associated with Smoking, Overweight and Obesity, and Alcohol Intake in Ireland During 2016","author":"National Cancer Registry Ireland","year":"2020"},{"key":"2026040911294350600_ckaf225-B22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1055\/s-0042-119993","article-title":"Does CIN2 have the same aggressive potential as CIN3? A secondary analysis of high-grade cytology recurrence in women treated with cold-coagulation cervical treatment","volume":"77","author":"Papoutsis","year":"2017","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"2026040911294350600_ckaf225-B23","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.3390\/cancers13225737","article-title":"A gene signature identifying CIN3 regression and cervical cancer survival","volume":"13","author":"Halle","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026040911294350600_ckaf225-B24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/ijc.23922","article-title":"How many cervical cancers are prevented by treatment of screen-detected disease in young women?","volume":"124","author":"Sasieni","year":"2009","journal-title":"Int J Cancer"},{"key":"2026040911294350600_ckaf225-B25","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1159\/000326673","article-title":"CIN 2\/3 and cervical cancer after an ASCUS pap smear: a 7-year, prospective study of the Norwegian population-based, coordinated screening program","volume":"47","author":"Nyg\u00e5rd","year":"2003","journal-title":"Acta Cytol"},{"key":"2026040911294350600_ckaf225-B26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/jnci\/djz227","article-title":"Estimating the natural history of cervical carcinogenesis using simulation models: a CISNET comparative analysis","volume":"112","author":"Burger","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"2026040911294350600_ckaf225-B27","author":"National Cancer Registry of Ireland","year":"2022"},{"key":"2026040911294350600_ckaf225-B28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1186\/1471-2407-14-505","article-title":"Estimation of savings of life-years and cost from early detection of cervical cancer: a follow-up study using nationwide databases for the period 2002\u20132009","volume":"14","author":"Hung","year":"2014","journal-title":"BMC Cancer"},{"key":"2026040911294350600_ckaf225-B29","doi-asserted-by":"crossref","first-page":"e900","DOI":"10.1136\/bmj.e900","article-title":"Screening and cervical cancer cure: population based cohort study","volume":"344","author":"Andrae","year":"2012","journal-title":"BMJ"},{"key":"2026040911294350600_ckaf225-B30","doi-asserted-by":"crossref","first-page":"e2115321","DOI":"10.1001\/jamanetworkopen.2021.15321","article-title":"Modeling cervical cancer screening strategies with varying levels of human papillomavirus vaccination","volume":"4","author":"Grimes","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026040911294350600_ckaf225-B31","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.vaccine.2019.11.081","article-title":"Human papillomavirus vaccination coverage, policies, and practical implementation across Europe","volume":"38","author":"Nguyen-Huu","year":"2020","journal-title":"Vaccine"},{"key":"2026040911294350600_ckaf225-B32","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0140-6736(18)30854-7","article-title":"Rapid response to HPV vaccination crisis in Ireland","volume":"391","author":"Corcoran","year":"2018","journal-title":"Lancet"},{"key":"2026040911294350600_ckaf225-B33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bmjebm-2021-111773","article-title":"Balancing benefits and potential risks of vaccination: the precautionary principle and the law of unintended consequences","volume":"27","author":"Grimes","year":"2022","journal-title":"BMJ Evid Based Med"},{"key":"2026040911294350600_ckaf225-B34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13814788.2020.1851677","article-title":"A qualitative study of parental views of HPV vaccination in Ireland","volume":"27","author":"Creed","year":"2021","journal-title":"Eur J Gen Pract"},{"key":"2026040911294350600_ckaf225-B35","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S2468-2667(18)30183-X","article-title":"The projected timeframe until cervical cancer elimination in Australia: a modelling study","volume":"4","author":"Hall","year":"2019","journal-title":"Lancet Public Health"},{"key":"2026040911294350600_ckaf225-B36","doi-asserted-by":"crossref","first-page":"e078551","DOI":"10.1136\/bmjopen-2023-078551","article-title":"Impact of human papillomavirus age-related prevalence and vaccination levels on interpretation of cervical screening modalities: a modelling study","volume":"14","author":"Grimes","year":"2024","journal-title":"BMJ Open"},{"key":"2026040911294350600_ckaf225-B37","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11845-023-03551-y","article-title":"The effect of HPV vaccination on the rate of high-grade cytology in 25-year-old women attending cervical screening in Ireland","volume":"193","author":"Rourke","year":"2024","journal-title":"Ir J Med Sci"},{"key":"2026040911294350600_ckaf225-B38","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1016\/j.vaccine.2008.07.098","article-title":"Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model","volume":"26","author":"Usher","year":"2008","journal-title":"Vaccine"},{"key":"2026040911294350600_ckaf225-B39","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2468-2667(16)30001-9","article-title":"Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models","volume":"1","author":"Brisson","year":"2016","journal-title":"Lancet Public Health"},{"key":"2026040911294350600_ckaf225-B40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejca.2019.12.013","article-title":"Effect of organized cervical cancer screening on cervical cancer mortality in Europe: a systematic review","volume":"127","author":"Jansen","year":"2020","journal-title":"Eur J Cancer (1965)"}],"container-title":["European Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurpub\/advance-article-pdf\/doi\/10.1093\/eurpub\/ckaf225\/66008494\/ckaf225.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurpub\/article-pdf\/36\/2\/ckaf225\/66008494\/ckaf225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurpub\/article-pdf\/36\/2\/ckaf225\/66008494\/ckaf225.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T15:49:16Z","timestamp":1775749756000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurpub\/article\/doi\/10.1093\/eurpub\/ckaf225\/8383798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurpub\/ckaf225","relation":{},"ISSN":["1101-1262","1464-360X"],"issn-type":[{"value":"1101-1262","type":"print"},{"value":"1464-360X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,12,19]]},"article-number":"ckaf225"}}